Arsenic Trioxide as Effective Therapy for Relapsed Acute Promyelocytic Leukemia

    Jami Mayorga, Carron Richardson-Hardin, Karel A. Dicke
    Studysummary This article discusses arsenic trioxide as a treatment for refractory or relapsed acute promyelocytic leukemia, noting its effectiveness and manageable side effects.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community โ†’